Hang Lung Group's (HKG:10) Soft Earnings Don't Show The Whole Picture
Hang Lung Group's (HKG:10) Soft Earnings Don't Show The Whole Picture
The market for Hang Lung Group Limited's (HKG:10) shares didn't move much after it posted weak earnings recently. Our analysis suggests that while the profits are soft, the foundations of the business are strong.
恒隆集团有限公司(HKG: 10)在最近公布疲软的收益后,其股票市场没有太大波动。我们的分析表明,尽管利润疲软,但业务基础却很牢固。
The Impact Of Unusual Items On Profit
不寻常物品对利润的影响
Importantly, our data indicates that Hang Lung Group's profit was reduced by HK$993m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. Assuming those unusual expenses don't come up again, we'd therefore expect Hang Lung Group to produce a higher profit next year, all else being equal.
重要的是,我们的数据显示,恒隆集团的利润比去年减少了9.93亿港元,这是由于不寻常的项目。看到不寻常的项目使公司利润付出代价从来都不是一件好事,但从好的方面来看,情况可能迟早会好转。我们调查了数千家上市公司,发现不寻常的物品本质上往往是一次性的。而且,毕竟,这正是会计术语的含义。假设这些不寻常的支出不会再次出现,因此,我们预计恒隆集团在其他条件相同的情况下,明年将实现更高的利润。
Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Hang Lung Group.
注意:我们始终建议投资者检查资产负债表的实力。点击此处查看我们对恒隆集团的资产负债表分析。
Our Take On Hang Lung Group's Profit Performance
我们对恒隆集团盈利表现的看法
Unusual items (expenses) detracted from Hang Lung Group's earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Hang Lung Group's statutory profit actually understates its earnings potential! And the EPS is up 29% annually, over the last three years. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. So while earnings quality is important, it's equally important to consider the risks facing Hang Lung Group at this point in time. Be aware that Hang Lung Group is showing 2 warning signs in our investment analysis and 1 of those can't be ignored...
去年,不寻常的项目(支出)减少了恒隆集团的收益,但明年我们可能会看到改善。基于这一观察,我们认为恒隆集团的法定利润可能实际上低估了其盈利潜力!在过去三年中,每股收益每年增长29%。本文的目标是评估我们在多大程度上可以依靠法定收益来反映公司的潜力,但还有很多需要考虑的地方。因此,尽管盈利质量很重要,但考虑恒隆集团目前面临的风险同样重要。请注意,恒隆集团在我们的投资分析中显示了两个警告信号,其中一个不容忽视...
This note has only looked at a single factor that sheds light on the nature of Hang Lung Group's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.
本报告仅研究了揭示恒隆集团利润性质的单一因素。但是,还有很多其他方法可以让你对公司的看法。例如,许多人认为高股本回报率是有利的商业经济的标志,而另一些人则喜欢 “关注资金”,寻找内部人士正在买入的股票。虽然可能需要你进行一些研究,但你可能会发现这份免费收集的拥有高股本回报率的公司,或者这份拥有大量内幕持股的股票清单很有用。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有反馈吗?对内容感到担忧吗?请直接联系我们。或者,也可以发送电子邮件至编辑团队 (at) simplywallst.com。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。